美国按种族划分的膀胱过度活动症先进治疗方式差异
研究利用TriNetX Diamond网络数据,纳入诊断为尿急尿失禁或膀胱过度活动症的成年女性,排除压力性或混合性尿失禁。共识别2,687,316例患者,其中白种人767,159例、黑种人108,464例。黑种人患者接受治疗的比例为16.6%,白种人为20.4%。倾向性评分匹配后,白种人患者接受任何处方的比率仍显著高于黑种人患者。结论认为黑种人女性接受药物和微创治疗的处方率显著较低,这种差异可能源于处方差异而非诊断差异,需进一步研究。
要点
- 黑种人患者接受膀胱过度活动症治疗的比例为16.6%,白种人为20.4%。
- 在同时包含白种人和黑种人数据的美国邮编区域,白种人处方率均显著更高。
- 倾向性评分匹配后,白种人接受任何处方的比率仍显著高于黑种人。
核心结论
- 黑种人女性接受药物和微创治疗的处方率显著低于白种人女性。
- 这种先进治疗方式的种族差异可能并非继发于诊断差异,而可能源于处方差异。
- 需要进一步研究以理解这些差异。
研究设计与样本
- 查询TriNetX Diamond网络,识别诊断为尿急尿失禁或膀胱过度活动症的成年女性,排除压力性尿失禁或混合性尿失禁者。
- 治疗按美国泌尿外科协会(AUA)指南定义为行为治疗、药物治疗或微创治疗。
- 使用贪婪最近邻算法对多个协变量进行倾向性评分匹配。
- 采用Cox比例风险回归分析比较匹配队列。
- 通过卡方检验或Fisher精确检验比较3位邮编区域的治疗率,并使用STATA 17.0生成地理分布图。
主要发现
- 共识别2,687,316例诊断为膀胱过度活动症的成年女性,其中白种人767,159例,黑种人108,464例。
- 黑种人患者中16.6%接受膀胱过度活动症治疗,白种人患者中20.4%接受治疗。
- 倾向性评分匹配后,两组处方差异持续存在,白种人患者接受任何处方的比率更高。
局限性
- 需要进一步研究以理解这些差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the impact of race on prescription patterns of therapies for overactive bladder (OAB). METHODS: The TriNetX Diamond network was queried to identify adult females with a diagnosis of urinary urgency incontinence (UUI) or OAB, excluding those with stress incontinence or mixed incontinence. Treatments were defined as behavioral, medical, or minimally invasive in accordance with American Urological Association (AUA) guidelines. Propensity-score matching for multiple covariates was performed using the greedy nearest-neighbor algorithm. Cox proportional hazards regression analysis was employed to compare the matched cohorts. Rates of treatment by 3-digit zip codes were compared through chi-square tests or Fisher's exact tests and geographic distribution maps were generated via STATA 17.0. RESULTS: We identified 2,687,316 adult females diagnosed with OAB; 767,159 identified as White and 108,464 as Black. Within these cohorts, 16.6% of Black patients and 20.4% of White patients received OAB treatment. Twenty-six-point three percent of US zip codes contained data for both White and Black patients, and in all these zip codes, White patients received significantly higher rates of prescriptions compared to Black patients. After propensity-score matching, significant differences in prescriptions persisted between the 2 groups with White patients exhibiting higher rates of any prescription. CONCLUSION: Our results demonstrate a significantly lower rate of prescriptions of medical and minimally invasive therapies for Black women. These racial differences in prescription of advanced therapeutic modalities for OAB may not be secondary to diagnosis but are likely secondary to prescribing disparities. Further research is needed to understand these differences.
引用
- An C, Agrawal P, Grutman A, et al. Differences in Advanced Therapeutic Modalities for Overactive Bladder in the United States by Race. Urology. 2024. PMID: 39357578. doi:10.1016/j.urology.2024.09.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。